CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,861,000 | +75.7% | 36,026 | -15.7% | 0.02% | +112.5% |
| Q2 2022 | $1,059,000 | -7.9% | 42,736 | -6.9% | 0.01% | +14.3% |
| Q1 2022 | $1,150,000 | -21.7% | 45,886 | +13.7% | 0.01% | -12.5% |
| Q4 2021 | $1,469,000 | +49.1% | 40,357 | -29.9% | 0.01% | +33.3% |
| Q3 2021 | $985,000 | +11.9% | 57,581 | -12.4% | 0.01% | +20.0% |
| Q2 2021 | $880,000 | -49.4% | 65,742 | +93.6% | 0.01% | -54.5% |
| Q1 2021 | $1,740,000 | -17.5% | 33,966 | -0.3% | 0.01% | -15.4% |
| Q4 2020 | $2,108,000 | – | 34,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |